NIRKO |
brain-specific |
Nestin-Cre
|
increased food intake in females;
mild insulin resistance and dyslipidemia;
hypothalamic hypogonadism;
loss of insulin stimulated PIP3 signaling
Tau hyperphosphorylation;
attenuated phosphorylated hepatic STAT3;
impaired GLUT4 translocation;
brain mitochondrial dysfunction;
dopaminergic dysfunction;
late-age onset-related anxiety- and depression-like behaviors
|
Regulation of energy disposal, fuel metabolism, reproduction, brain-liver crosstalk, glucose sensing, brain cholesterol metabolism, mitochondrial function, and dopamine signaling |
[5, 6, 42–44, 107, 142] |
GIRKO |
Astrocyte-specific |
GFAP-Cre, GFAP-CreERT2, GLAST-CreERT2
|
impaired responses to changes in glucose availability;
decreased ATP release from astrocytes;
anxiety- and depression-like behaviors;
longer and irregular estrus cycles;
decreased pregnancy rates and reduced litter sizes;
dysregulation of the HPG axis
|
hypothalamic glucose sensing, regulation of systemic glucose metabolism, dopaminergic signaling, ATP exocytosis, HPG axis |
[7, 62, 143] |
EndoIRKO |
Vascular endothelial cells-specific |
Cdh5-Cre Slcolc1-CreERT2
|
delayed onset of insulin signaling in the brain;
decreased levels of hypothalamic POMC, increased food intake and obesity;
delayed acute hypoglycemic effect of systemic insulin administration and impaired glucose tolerance;
Not necessary to maintain insulin sensitivity
|
Transendothelial insulin delivery; kinetics of insulin signaling |
[74, 77, 79] |